Singapore markets open in 2 hours 41 minutes

Nuwellis, Inc. (NUWE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1330-0.0214 (-13.86%)
At close: 04:00PM EDT
0.1350 +0.00 (+1.50%)
After hours: 06:19PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.1544
Open0.1550
Bid0.1250 x 500
Ask0.0000 x 0
Day's range0.1256 - 0.1550
52-week range0.1256 - 4.7800
Volume2,803,167
Avg. volume1,408,875
Market cap904,591
Beta (5Y monthly)0.17
PE ratio (TTM)N/A
EPS (TTM)-11.5200
Earnings date07 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est9.00
  • GlobeNewswire

    Nuwellis Announces Closing of $2.7 Million Public Offering

    MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload, today announced the closing of its previously announced public offering of 11,250,000 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to an aggregate of 16,875,000 shares of its common stock at a combined public offering price of $0.24 per share (or

  • GlobeNewswire

    Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024

    MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the first quarter of 2024 on Tuesday, May 7, 2024. Nuwellis will host a conference call and webcast at 9:00 AM ET to discuss its financial results and provide a general business update. To access the live webcast, please visit the Investors page of the Nuwellis websit

  • GlobeNewswire

    Nuwellis Announces Pricing of $2.7 Million Public Offering

    MINNEAPOLIS, April 26, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload, today announced the pricing of a public offering of 11,250,000 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to an aggregate of 16,875,000 shares of its common stock at a combined public offering price $0.24 per share (or pre-funded warrant in lie